HEADER CARBOHYDRATE-BINDING PROTEIN 01-JUL-09 3I4G TITLE CRYSTAL STRUCTURE OF A SUSD-LIKE CARBOHYDRATE BINDING PROTEIN (BF0978) TITLE 2 FROM BACTEROIDES FRAGILIS NCTC 9343 AT 1.35 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUSD-LIKE CARBOHYDRATE BINDING PROTEIN BF1063; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES FRAGILIS NCTC 9343; SOURCE 3 ORGANISM_TAXID: 272559; SOURCE 4 GENE: BF0978, YP_210668.1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS SUSD-LIKE CARBOHYDRATE BINDING PROTEIN, STRUCTURAL GENOMICS, JOINT KEYWDS 2 CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, KEYWDS 3 PSI-2, CARBOHYDRATE-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3I4G 1 REMARK SEQADV REVDAT 5 24-JUL-19 3I4G 1 REMARK LINK REVDAT 4 25-OCT-17 3I4G 1 REMARK REVDAT 3 13-JUL-11 3I4G 1 VERSN REVDAT 2 28-JUL-10 3I4G 1 HEADER TITLE KEYWDS REVDAT 1 21-JUL-09 3I4G 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF SUSD-LIKE CARBOHYDRATE BINDING PROTEIN JRNL TITL 2 BF1063 FROM BACTEROIDES FRAGILIS YCH46 (YP_210668.1) FROM JRNL TITL 3 BACTEROIDES FRAGILIS NCTC 9343 AT 1.35 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 112791 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.139 REMARK 3 R VALUE (WORKING SET) : 0.138 REMARK 3 FREE R VALUE : 0.157 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5645 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.39 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7471 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.06 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 404 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4107 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 743 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 10.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.44000 REMARK 3 B22 (A**2) : 0.53000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.046 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.048 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.028 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.370 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.974 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.967 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4509 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3081 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6145 ; 1.526 ; 1.947 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7479 ; 1.075 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 567 ; 4.570 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 224 ;36.105 ;24.152 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 727 ; 9.799 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;12.571 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 629 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5201 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 968 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 954 ; 0.220 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3483 ; 0.194 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2340 ; 0.190 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 2119 ; 0.089 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 1086 ; 0.185 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 8 ; 0.102 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 25 ; 0.141 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 56 ; 0.215 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2924 ; 1.435 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1088 ; 0.336 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4423 ; 1.768 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2014 ; 2.731 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1722 ; 3.568 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 33 A 545 REMARK 3 ORIGIN FOR THE GROUP (A): 10.2548 62.8772 21.2414 REMARK 3 T TENSOR REMARK 3 T11: -0.0186 T22: -0.0211 REMARK 3 T33: -0.0129 T12: 0.0061 REMARK 3 T13: 0.0011 T23: -0.0017 REMARK 3 L TENSOR REMARK 3 L11: 0.2486 L22: 0.1975 REMARK 3 L33: 0.2380 L12: 0.0535 REMARK 3 L13: 0.0218 L23: -0.0671 REMARK 3 S TENSOR REMARK 3 S11: 0.0069 S12: 0.0134 S13: -0.0114 REMARK 3 S21: -0.0002 S22: -0.0022 S23: -0.0080 REMARK 3 S31: 0.0344 S32: 0.0098 S33: -0.0047 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.ATOM RECORD CONTAINS RESIDUAL B FACTORS REMARK 3 ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REMARK 3 REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. REMARK 3 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID (EPE) FROM REMARK 3 THE PROTEIN PREPARATION AND ETHYLENE GLYCOL (EDO), A REMARK 3 CRYOPROTECTANT, ARE MODELED INTO THE STRUCTURE. REMARK 4 REMARK 4 3I4G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000053951. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97932,0.97918 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112883 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 29.223 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.480 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.50200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: DATA WERE SCALED USING XSCALE WITH FRIEDEL PAIRS KEPT AS REMARK 200 SEPARATE WHEN COMPUTING R-SYM, COMPLETENESS AND OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.84250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.37000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.20750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.37000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.84250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.20750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY PROVIDES REMARK 300 SUPPORTING EVIDENCE THAT THE MONOMER IS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 CYS A 20 REMARK 465 ASP A 21 REMARK 465 LEU A 22 REMARK 465 GLU A 23 REMARK 465 ARG A 24 REMARK 465 TYR A 25 REMARK 465 PRO A 26 REMARK 465 LEU A 27 REMARK 465 THR A 28 REMARK 465 ASP A 29 REMARK 465 LEU A 30 REMARK 465 SER A 31 REMARK 465 GLU A 32 REMARK 465 ASP A 546 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 33 CG CD OE1 OE2 REMARK 470 ARG A 51 NE CZ NH1 NH2 REMARK 470 LYS A 115 NZ REMARK 470 ARG A 122 CZ NH1 NH2 REMARK 470 GLU A 171 CG CD OE1 OE2 REMARK 470 LYS A 186 CE NZ REMARK 470 LYS A 453 CE NZ REMARK 470 LYS A 520 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 462 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MSE A 71 -74.07 -108.25 REMARK 500 LYS A 159 -64.99 75.54 REMARK 500 TYR A 279 -108.15 -121.80 REMARK 500 ASN A 328 88.64 -154.15 REMARK 500 ASP A 334 128.74 -38.25 REMARK 500 TYR A 383 -2.44 84.55 REMARK 500 SER A 395 80.72 -156.71 REMARK 500 THR A 431 -94.99 -117.83 REMARK 500 ALA A 522 59.70 -142.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 9 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 396566 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. THE CLONED REMARK 999 CONSTRUCT CONTAINS RESIDUES 20-546 OF THE FULL LENGTH PROTEIN. DBREF 3I4G A 20 546 UNP Q5LGM0 Q5LGM0_BACFN 20 546 SEQADV 3I4G GLY A 0 UNP Q5LGM0 EXPRESSION TAG SEQRES 1 A 528 GLY CYS ASP LEU GLU ARG TYR PRO LEU THR ASP LEU SER SEQRES 2 A 528 GLU GLU THR PHE TRP ASN SER GLU SER ASN ALA GLU LEU SEQRES 3 A 528 ALA LEU THR SER LEU TYR ARG GLY SER LEU THR ASP GLY SEQRES 4 A 528 VAL GLU TYR ASN PRO SER ASP TRP TRP SER TYR HIS GLY SEQRES 5 A 528 MSE ILE MSE MSE GLU HIS LEU SER ASP ASN ALA PHE ASP SEQRES 6 A 528 ARG ARG GLY GLU ASN ASN PRO PHE PHE LYS ILE SER SER SEQRES 7 A 528 GLY ASN LEU THR ALA ASP ASN ALA PHE ILE LYS ARG TYR SEQRES 8 A 528 TRP GLU THR SER TYR LYS ARG ILE GLY TYR CYS ASN ARG SEQRES 9 A 528 PHE LEU VAL GLY ILE GLN ASN SER SER GLU SER GLU LYS SEQRES 10 A 528 LYS THR ARG MSE ILE ALA GLU ALA ARG PHE LEU ARG ALA SEQRES 11 A 528 THR GLN TYR PHE TYR LEU ALA SER TYR PHE LYS ASN VAL SEQRES 12 A 528 PRO LEU VAL GLU ASN VAL LEU THR GLY GLU GLU ALA ASN SEQRES 13 A 528 ASN VAL THR LYS THR SER GLN ALA ASP ILE LEU LYS TRP SEQRES 14 A 528 CYS VAL THR GLU PHE THR ALA ALA ALA ALA ASP LEU PRO SEQRES 15 A 528 ARG PHE SER ALA ILE PRO ALA GLY GLU ALA GLY ARG ALA SEQRES 16 A 528 CYS LYS GLN ALA ALA LEU ALA PHE LEU GLY ARG THR CYS SEQRES 17 A 528 MSE LEU GLN LYS ASP TRP LYS SER GLY ALA LYS ALA PHE SEQRES 18 A 528 HIS ASP ILE MSE GLU LEU GLY ASP ASN ALA ILE ASN ALA SEQRES 19 A 528 ASN TYR GLN GLU LEU PHE TYR PRO SER THR GLY THR SER SEQRES 20 A 528 ASN LYS GLU ASN ILE PHE TYR ILE GLN TYR LEU GLU ASN SEQRES 21 A 528 TYR LEU GLY THR GLY LEU PRO GLN HIS ALA LEU SER ALA SEQRES 22 A 528 LYS ASP GLY GLY TRP SER LEU VAL ASN PRO ALA ALA ASP SEQRES 23 A 528 LEU TYR GLU SER TYR GLU PHE LYS ASP GLY THR PRO PHE SEQRES 24 A 528 SER TYR ASP ASP PRO ARG TYR ASP PRO SER ASN LEU GLY SEQRES 25 A 528 LYS ASP ARG ASP PRO ARG LEU ASP TYR THR ILE TYR TYR SEQRES 26 A 528 ASN GLY ALA ILE PHE MSE GLY THR GLU TYR LYS MSE SER SEQRES 27 A 528 PRO ASP TYR SER ALA ALA LYS LYS GLU LYS LEU ASP TYR SEQRES 28 A 528 THR SER GLU ALA SER ARG THR GLY PHE MSE MSE ARG LYS SEQRES 29 A 528 TYR PHE GLU GLU SER THR PRO ILE ASN ASP VAL GLN SER SEQRES 30 A 528 ALA ASN GLY LEU THR PRO VAL ILE ARG TYR ALA GLU VAL SEQRES 31 A 528 LEU LEU GLY TYR LEU GLU CYS LEU VAL GLU ASP ASN GLN SEQRES 32 A 528 THR ILE THR GLN GLY ILE LEU ASP GLU THR ILE ASN ALA SEQRES 33 A 528 VAL ARG GLY ARG ALA SER VAL ASN MSE PRO PRO VAL THR SEQRES 34 A 528 GLU VAL THR PRO ALA LYS LEU ARG GLU ILE VAL ARG HIS SEQRES 35 A 528 GLU ARG ARG ILE GLU LEU ALA MSE GLU GLY ILE ARG TYR SEQRES 36 A 528 TRP ASP ILE MSE ARG TRP GLY ILE ALA HIS GLU VAL LEU SEQRES 37 A 528 SER GLN LYS ILE TRP GLY ALA PRO TYR PRO GLY SER THR SEQRES 38 A 528 GLN TYR ALA THR THR THR LYS GLU VAL ASP PRO THR GLY SEQRES 39 A 528 ASN TYR ARG TRP TYR VAL GLY LYS ARG ALA PHE ARG ASN SEQRES 40 A 528 PRO THR ASP TYR THR TRP PRO ILE PRO GLN SER GLU GLN SEQRES 41 A 528 ASN ILE ASN PRO ASN LEU ARG ASP MODRES 3I4G MSE A 71 MET SELENOMETHIONINE MODRES 3I4G MSE A 73 MET SELENOMETHIONINE MODRES 3I4G MSE A 74 MET SELENOMETHIONINE MODRES 3I4G MSE A 139 MET SELENOMETHIONINE MODRES 3I4G MSE A 227 MET SELENOMETHIONINE MODRES 3I4G MSE A 243 MET SELENOMETHIONINE MODRES 3I4G MSE A 349 MET SELENOMETHIONINE MODRES 3I4G MSE A 355 MET SELENOMETHIONINE MODRES 3I4G MSE A 379 MET SELENOMETHIONINE MODRES 3I4G MSE A 380 MET SELENOMETHIONINE MODRES 3I4G MSE A 443 MET SELENOMETHIONINE MODRES 3I4G MSE A 468 MET SELENOMETHIONINE MODRES 3I4G MSE A 477 MET SELENOMETHIONINE HET MSE A 71 8 HET MSE A 73 8 HET MSE A 74 8 HET MSE A 139 8 HET MSE A 227 16 HET MSE A 243 8 HET MSE A 349 8 HET MSE A 355 8 HET MSE A 379 8 HET MSE A 380 8 HET MSE A 443 8 HET MSE A 468 8 HET MSE A 477 8 HET EPE A 1 15 HET EDO A 2 4 HET EDO A 3 4 HET EDO A 4 4 HET EDO A 5 8 HET EDO A 6 4 HET EDO A 7 4 HET EDO A 8 4 HET EDO A 9 4 HETNAM MSE SELENOMETHIONINE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EPE HEPES HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 13(C5 H11 N O2 SE) FORMUL 2 EPE C8 H18 N2 O4 S FORMUL 3 EDO 8(C2 H6 O2) FORMUL 11 HOH *743(H2 O) HELIX 1 1 THR A 34 ASN A 37 5 4 HELIX 2 2 SER A 38 GLY A 52 1 15 HELIX 3 3 MSE A 71 SER A 78 5 8 HELIX 4 4 ASN A 89 GLY A 97 1 9 HELIX 5 5 ASN A 103 GLN A 128 1 26 HELIX 6 6 SER A 133 PHE A 158 1 26 HELIX 7 7 THR A 169 ASN A 174 1 6 HELIX 8 8 SER A 180 LEU A 199 1 20 HELIX 9 9 ARG A 201 ILE A 205 5 5 HELIX 10 10 PRO A 206 ALA A 210 5 5 HELIX 11 11 CYS A 214 LYS A 230 1 17 HELIX 12 12 ASP A 231 GLY A 246 1 16 HELIX 13 13 TYR A 254 TYR A 259 5 6 HELIX 14 14 GLY A 283 LEU A 289 1 7 HELIX 15 15 SER A 290 GLY A 294 5 5 HELIX 16 16 ALA A 302 GLU A 307 1 6 HELIX 17 17 ASP A 334 THR A 340 1 7 HELIX 18 18 TYR A 405 ASP A 419 1 15 HELIX 19 19 THR A 424 THR A 431 1 8 HELIX 20 20 THR A 431 GLY A 437 1 7 HELIX 21 21 THR A 450 LEU A 466 1 17 HELIX 22 22 ILE A 471 TRP A 479 1 9 HELIX 23 23 ILE A 481 LEU A 486 1 6 HELIX 24 24 GLN A 500 THR A 505 1 6 HELIX 25 25 PRO A 526 THR A 530 5 5 HELIX 26 26 PRO A 534 ASN A 541 1 8 HELIX 27 27 PRO A 542 ARG A 545 5 4 SHEET 1 A 2 ALA A 81 ASP A 83 0 SHEET 2 A 2 VAL A 299 PRO A 301 -1 O ASN A 300 N PHE A 82 SHEET 1 B 2 ASN A 269 TYR A 275 0 SHEET 2 B 2 GLY A 398 ARG A 404 -1 O VAL A 402 N PHE A 271 SHEET 1 C 2 ILE A 341 TYR A 343 0 SHEET 2 C 2 PHE A 378 MSE A 380 -1 O MSE A 379 N TYR A 342 SHEET 1 D 2 ILE A 347 PHE A 348 0 SHEET 2 D 2 THR A 351 GLU A 352 -1 O THR A 351 N PHE A 348 SHEET 1 E 2 LYS A 489 PRO A 494 0 SHEET 2 E 2 ARG A 515 LYS A 520 -1 O GLY A 519 N ILE A 490 LINK C GLY A 70 N MSE A 71 1555 1555 1.33 LINK C MSE A 71 N ILE A 72 1555 1555 1.32 LINK C ILE A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N MSE A 74 1555 1555 1.33 LINK C MSE A 74 N GLU A 75 1555 1555 1.33 LINK C ARG A 138 N MSE A 139 1555 1555 1.32 LINK C MSE A 139 N ILE A 140 1555 1555 1.33 LINK C CYS A 226 N AMSE A 227 1555 1555 1.33 LINK C CYS A 226 N BMSE A 227 1555 1555 1.33 LINK C AMSE A 227 N LEU A 228 1555 1555 1.33 LINK C BMSE A 227 N LEU A 228 1555 1555 1.33 LINK C ILE A 242 N MSE A 243 1555 1555 1.32 LINK C MSE A 243 N AGLU A 244 1555 1555 1.32 LINK C MSE A 243 N BGLU A 244 1555 1555 1.33 LINK C PHE A 348 N MSE A 349 1555 1555 1.32 LINK C MSE A 349 N GLY A 350 1555 1555 1.32 LINK C ALYS A 354 N MSE A 355 1555 1555 1.34 LINK C BLYS A 354 N MSE A 355 1555 1555 1.33 LINK C MSE A 355 N SER A 356 1555 1555 1.33 LINK C PHE A 378 N MSE A 379 1555 1555 1.32 LINK C MSE A 379 N MSE A 380 1555 1555 1.34 LINK C MSE A 380 N ARG A 381 1555 1555 1.33 LINK C ASN A 442 N MSE A 443 1555 1555 1.33 LINK C MSE A 443 N PRO A 444 1555 1555 1.34 LINK C ALA A 467 N MSE A 468 1555 1555 1.33 LINK C MSE A 468 N GLU A 469 1555 1555 1.35 LINK C ILE A 476 N MSE A 477 1555 1555 1.32 LINK C MSE A 477 N ARG A 478 1555 1555 1.33 CISPEP 1 ASN A 525 PRO A 526 0 6.29 SITE 1 AC1 8 TYR A 60 ARG A 84 ARG A 85 HIS A 287 SITE 2 AC1 8 TRP A 296 GLU A 372 HOH A 844 HOH A1134 SITE 1 AC2 7 PRO A 285 TYR A 383 PHE A 384 GLU A 385 SITE 2 AC2 7 ASN A 397 HOH A 856 HOH A 959 SITE 1 AC3 5 ASN A 391 GLU A 507 TYR A 517 HOH A 583 SITE 2 AC3 5 HOH A 647 SITE 1 AC4 6 ASP A 304 VAL A 485 GLN A 488 HOH A 804 SITE 2 AC4 6 HOH A 807 HOH A1275 SITE 1 AC5 5 THR A 527 THR A 530 HOH A1060 HOH A1102 SITE 2 AC5 5 HOH A1165 SITE 1 AC6 6 TYR A 50 ARG A 51 ASP A 64 ARG A 116 SITE 2 AC6 6 ILE A 273 HOH A 898 SITE 1 AC7 8 GLU A 33 TRP A 36 ASN A 37 PRO A 90 SITE 2 AC7 8 ASN A 129 HOH A 617 HOH A 913 HOH A1076 SITE 1 AC8 5 LYS A 354 TYR A 359 GLU A 365 HOH A 688 SITE 2 AC8 5 HOH A1189 SITE 1 AC9 4 PRO A 162 ALA A 173 VAL A 176 HOH A 895 CRYST1 47.685 66.415 162.740 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020971 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015057 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006145 0.00000